Screener
BioCryst Pharmaceuticals BCRX Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.
The source filing: BioCryst Pharmaceuticals’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053300
FAQ
- What is BioCryst Pharmaceuticals's operating lease ROU assets?
- BioCryst Pharmaceuticals (BCRX) reported operating lease ROU assets of 10.1% in Q2 2026.
- How has BioCryst Pharmaceuticals's operating lease ROU assets changed year-over-year?
- BioCryst Pharmaceuticals's operating lease ROU assets decreased by 5.7% year-over-year, from 10.7% to 10.1%.
- What is the long-term trend for BioCryst Pharmaceuticals's operating lease ROU assets?
- Over 3 years (2022 to 2025), BioCryst Pharmaceuticals's operating lease ROU assets has grown at a -0.9% compound annual growth rate (CAGR), from 11% to 10.7%.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about BioCryst Pharmaceuticals's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude